OPUS GENETICS INC. - COMMON STOCK
1,1800
01-ноября-24 14:59:56
15 мин. задержка
Акции
-0,0200
-1,67%
Сегодняшний диапазон
1,1600 - 1,2185
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Ocuphire Expands Medical Advisory Board with Seven New KOLs and Strengthens Leadership Team
29 сен 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
15 сен 2022 06:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Receives PDFUA Fee Waiver for Nyxol New Drug Application from FDA
12 сен 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
08 сен 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at The H.C. Wainwright 24th Annual Global Investment Conference
06 сен 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
12 авг 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Upcoming Presentations at Two Conferences in August
08 авг 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
03 авг 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
07 июл 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
29 июн 2022 08:00:37 Источник Nasdaq GlobeNewswire
-
08 июн 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
19 май 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for First Quarter 2022 and Provides Corporate Update
13 май 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
11 май 2022 07:00:02 Источник Nasdaq GlobeNewswire
-
28 апр 2022 06:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Announces Upcoming Clinical Presentations at ARVO 2022 Medical Meeting and MODLive! 2022
26 апр 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
19 апр 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at Wet AMD & DME Drug Development Summit in Boston, MA
06 апр 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
29 мар 2022 06:00:01 Источник Nasdaq GlobeNewswire
-
24 мар 2022 07:00:01 Источник Nasdaq GlobeNewswire